Yuanbao (NASDAQ:YB – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.
A number of other equities analysts also recently commented on the company. Weiss Ratings reiterated a “hold (c)” rating on shares of Yuanbao in a research report on Monday, December 29th. Citigroup started coverage on Yuanbao in a research note on Monday. They issued a “neutral” rating and a $21.80 target price for the company. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold” and an average price target of $21.80.
View Our Latest Analysis on Yuanbao
Yuanbao Trading Up 1.2%
Yuanbao (NASDAQ:YB – Get Free Report) last announced its quarterly earnings results on Wednesday, December 3rd. The company reported $1.08 earnings per share (EPS) for the quarter. The company had revenue of $162.64 million during the quarter.
Institutional Trading of Yuanbao
A number of hedge funds and other institutional investors have recently bought and sold shares of the business. WFM ASIA BVI Ltd acquired a new stake in shares of Yuanbao in the 2nd quarter worth approximately $2,020,000. Susquehanna International Group LLP acquired a new position in Yuanbao during the third quarter worth $59,613,000. Barclays PLC boosted its position in Yuanbao by 68.7% during the fourth quarter. Barclays PLC now owns 41,988 shares of the company’s stock worth $851,000 after purchasing an additional 17,105 shares in the last quarter. JPMorgan Chase & Co. grew its holdings in Yuanbao by 53.7% in the third quarter. JPMorgan Chase & Co. now owns 33,226 shares of the company’s stock valued at $653,000 after purchasing an additional 11,607 shares during the last quarter. Finally, Federated Hermes Inc. purchased a new position in shares of Yuanbao in the second quarter valued at $370,000.
Yuanbao Company Profile
Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine. Through this engine, we successfully distribute suitable and high-quality insurance products to over ten million insurance consumers. According to Frost & Sullivan, we were the largest independent insurance distributor in China’s personal life and accident & health (A&H) insurance market in terms of first year premiums in 2023.
Featured Articles
- Five stocks we like better than Yuanbao
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- The Biggest IPO Ever… Open to Everyday Folks
- Read this or regret it forever
Receive News & Ratings for Yuanbao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yuanbao and related companies with MarketBeat.com's FREE daily email newsletter.
